Home » Newsletters » BioWorld

BioWorld

Feb. 4, 1994

View Archived Issues

MOLECULAR BIOSYSTEMS' ALBUNEX APPROVED IN SWEDEN

CENTOCOR REACQUIRES TOCOR II UNITS

ECOGEN LISTS WARRANTS

VERTEX UNDERWRITERS EXERCISE OVERALLOTMENT

ONCOR RAISES $24M FROM OFFERING

APPOINTMENTS AND ADVANCEMENTS

CANGUARD COMPLETES OFFERING

ZENECA SEEDS DEVELOPS GENE INSERTION TECHNOLOGY

ZENECA CREATES GENOME GROUP

CALGENE EXPECTS LARGE 1994 LOSS DUE TO SLOW FDA ACTION

CYGNUS, P&G TO DEVELOP SMOKING CESSATION PRODUCTS

BIOTECH START-UP LICENSES CELL DEATH GENES FROM M.I.T.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...